Activity-dependent patterning of retinogeniculate axons proceeds with a constant contribution from AMPA and NMDA receptors.
Neural activity is critical for the refinement of neural circuitry during development, although the mechanisms involved in stabilizing appropriate connectivity remain unclear. It has been proposed that the insertion of AMPA receptors at synapses with only NMDA receptors ("silent synapses") mediates this stabilization, leading to an increasing contribution from AMPA receptors as development proceeds. Here we show in a mammalian system known to undergo activity-dependent development [the segregation of retinal afferents into ON/OFF sublaminae in the ferret lateral geniculate nucleus (LGN)] that the refinement of the neural circuitry occurs in the presence of a constant functional contribution from AMPA and NMDA receptors. Although we detected a small number of silent synapses on LGN cells, their proportion did not decrease with age. The size and kinetics of NMDA-mediated spontaneous EPSCs (sEPSCs) were also stable over this period. Together with previous results reporting the stability of unitary AMPA-mediated EPSCs, the constancy of NMDA-mediated sEPSCs indicates an unchanging AMPA/NMDA contribution. Additionally, the CNQX-sensitivity did not increase for either sEPSCs or optic tract-evoked EPSCs. Likewise, the anatomical AMPA/NMDA ratio, as assayed by quantifying the colocalized expression of AMPA and NMDA receptor subunits, was fixed throughout ON/OFF sublamination. In particular, the colocalization of AMPA receptor subunits (GluR1 or GluR4) and NMDA receptor subunit NR1 opposite identified retinogeniculate terminals was stable during this period. These results add to the view of the population of retinogeniculate synapses as robustly stable or normalized during a period when retinogeniculate axons are undergoing dramatic activity-dependent refinement.
Hohnke
C D
CD
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Oray
S
S
Sur
M
M
D015763:2-Amino-5-phosphonovalerate; D000375:Aging / Q000502:physiology; D000818:Animals; D001370:Axonal Transport / Q000502:physiology; D001369:Axons / Q000378:metabolism*; D019521:Body Patterning; D002772:Cholera Toxin; D004558:Electric Stimulation; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials; D005289:Ferrets; D005829:Geniculate Bodies / Q000378:metabolism*; D066298:In Vitro Techniques; D011930:Reaction Time; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012160:Retina / Q000378:metabolism*; D013569:Synapses / Q000378:metabolism; D016708:Synaptophysin / Q000378:metabolism; D014795:Visual Pathways / Q000254:growth & development* / Q000378:metabolism
D015763:2-Amino-5-phosphonovalerate; D002772:Cholera Toxin; D018691:Excitatory Amino Acid Antagonists; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D016708:Synaptophysin; C409466:NR1 NMDA receptor; C104724:glutamate receptor ionotropic, AMPA 4